Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
I mean, methadone is a portion-controlled opioid used to treat heroin addiction. It’s traditionally meant to be weaned off of, but there are plenty of people that use it their whole life.
It’s the equivalent of sitting down with a dietician, making a meal plan, and holding yourself accountable to it. Addiction only ends when the user is willing to commit to the action.
To come full circle, that’s what GLP-1 drugs are. A medical intervention for an addiction. Same as methadone. It’s not a coincidence that GLP-1 drugs also curb cravings for other addictive behaviors.
And that’s why the snark of the “Did you know you can just eat less to lose weight?” falls flat, because it’s completely uninformed.